Article info
Oral Featured Posters
OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients
Citation
OP013/#417 Cost-effectiveness of dostarlimab in advanced recurrent deficient mismatch repair endometrial cancer patients
Publication history
- First published November 1, 2021.
Online issue publication
November 01, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© IGCS and ESGO 2021. No commercial re-use. See rights and permissions. Published by BMJ.